Stockreport

H.C Wainwright Asserts Buy Stance as ImmunityBio, Inc. (IBRX) Achieves Positive Results on Bladder Cancer Treatment [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF clinical trial results for its ANKTIVA plus BCG treatment. The candidate drug being trialed in high-grade papillary non-muscle invasive bladder cancer demonstrated stron [Read more]